arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2209.03116cs.CV
收藏

一种高精度评估肿瘤治疗反应变化的新方法

A New Method for the High-Precision Assessment of Tumor Changes in Response to Treatment

University of Manchester(曼彻斯特大学)

P. D. Tar, N. A. Thacker, J. P. B. O'Connor

摘要:

成像表明,临床前和人类肿瘤是异质性的,即单个肿瘤可以表现出多个区域,这些区域在正常发育期间以及对治疗的反应中表现不同。在对照组肿瘤中观察到的大的变化可能由于归因于变化原因的模糊性而使显著治疗效果的检测变得模糊。这可能会阻碍有效疗法的发展,这是由于实验设计的局限性,而不是由于治疗失败。描述了一种用于对成像信号中的生物变化和异质性进行建模的改进方法。具体而言,线性泊松模型(LPM)评估了两种结肠直肠癌异种移植模型中放疗前和放疗后72小时表观扩散系数(ADC)的变化。将测量变化的统计显著性与使用常规t检验分析基本ADC分布参数可获得的统计显著性进行比较。当LPM应用于治疗的肿瘤时,LPM检测到高度显著的变化。与传统方法相比,所有肿瘤的分析都是显著的,相当于功效增加4倍(即相当于样本量增加16倍)。相比之下,使用t检验仅在队列水平上检测到高度显著的变化,限制了它们在个性化医疗中的潜在用途,并增加了测试期间所需的动物数量。此外,LPM能够估计每个异种移植模型的响应和非响应组织的相对体积。经处理异种移植物的留一法分析提供了质量控制,并确定了潜在的离群值,提高了临床相关样本量下LPM数据的置信度。

英文摘要:

Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both normal development and also in response to treatment. The large variations observed in control group tumors can obscure detection of significant therapeutic effects due to the ambiguity in attributing causes of change. This can hinder development of effective therapies due to limitations in experimental design, rather than due to therapeutic failure. An improved method to model biological variation and heterogeneity in imaging signals is described. Specifically, Linear Poisson modelling (LPM) evaluates changes in apparent diffusion co-efficient (ADC) before and 72 hours after radiotherapy, in two xenograft models of colorectal cancer. The statistical significance of measured changes are compared to those attainable using a conventional t-test analysis on basic ADC distribution parameters. When LPMs were applied to treated tumors, the LPMs detected highly significant changes. The analyses were significant for all tumors, equating to a gain in power of 4 fold (i.e. equivelent to having a sample size 16 times larger), compared with the conventional approach. In contrast, highly significant changes are only detected at a cohort level using t-tests, restricting their potential use within personalised medicine and increasing the number of animals required during testing. Furthermore, LPM enabled the relative volumes of responding and non-responding tissue to be estimated for each xenograft model. Leave-one-out analysis of the treated xenografts provided quality control and identified potential outliers, raising confidence in LPM data at clinically relevant sample sizes.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑